Published in Am J Pathol on May 01, 1973
Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev (1989) 1.79
Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection. Infect Immun (1986) 1.71
Immunopathology of experimental cutaneous leishmaniasis. Am J Pathol (1984) 1.65
Th2 cell hyporesponsiveness during chronic murine schistosomiasis is cell intrinsic and linked to GRAIL expression. J Clin Invest (2009) 1.43
Studies on the host-parasite relationship in Schistosoma mansoni-infected mice: the immunological dependence of parasite egg excretion. Immunology (1978) 1.11
Th2 responses in schistosomiasis. Semin Immunopathol (2012) 1.04
Immunology of human schistosomiasis. Parasite Immunol (2014) 0.99
Epidemiology and interactions of Human Immunodeficiency Virus - 1 and Schistosoma mansoni in sub-Saharan Africa. Infect Dis Poverty (2013) 0.98
Serum protein concentrations during Schistosoma mansoni infection in intact and T-cell deprived mice. I. The acute phase proteins, C3 and serum amyloid P-component (SAP). Immunology (1980) 0.93
Etiology of the liver granulomatous response in Schistosoma mansoni-infected athymic nude mice. Infect Immun (1980) 0.92
Immunogenetic analysis of patients with post-schistosomal liver cirrhosis in man. Clin Exp Immunol (1982) 0.86
The effects of T cell deficiency on the development of worms and granuloma formation in mice infected with Schistosoma japonicum. Parasitol Res (2008) 0.85
Cell-mediated immunity and its role in resistance to infection. West J Med (1977) 0.85
Activity of artemether and mefloquine against juvenile and adult Schistosoma mansoni in athymic and immunocompetent NMRI mice. Am J Trop Med Hyg (2010) 0.84
Proteomic identification of IPSE/alpha-1 as a major hepatotoxin secreted by Schistosoma mansoni eggs. PLoS Negl Trop Dis (2011) 0.81
Potentiation of schistosome granuloma formation. By lentinan--a T-cell adjuvant. Am J Pathol (1979) 0.80
Regulation of the development of the hepatic B cell compartment during Schistosoma mansoni infection. J Immunol (2013) 0.79
[The immunology of schistosomiasis]. Bull World Health Organ (1976) 0.75
Immunology of schistosomiasis. Bull World Health Organ (1974) 0.75
Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol (1967) 4.04
An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg (1967) 3.10
The inhibition of granuloma formation around Schistosoma mansoni eggs. II. Thymectomy. Am J Pathol (1967) 2.23
STUDIES ON GRANULOMA FORMATION. III. ANTIGEN SEQUESTRATION AND DESTRUCTION IN THE SCHISTOSOME PSEUDOTUBERCLE. Am J Pathol (1964) 2.15
The inhibition of granuloma formation around Schistosoma mansoni eggs. 3. Heterologous antilymphocyte serum. Am J Pathol (1968) 1.58
Schistosomal egg antigen-induced lymphocyte blastogenesis in experimental murine Schistosoma mansoni infection. J Immunol (1971) 1.33
Studies on the passage of helminth larvae through host tissues. I. Histochemical studies on the extracellular changes caused by penetrating larvae. II. Enzymatic activity of larvae in vitro and in vivo. J Infect Dis (1954) 1.24
Schistosoma mansoni: eosinophilia and the development of lymphocyte blastogenesis in response to soluble egg antigen in inbred mice. Exp Parasitol (1972) 1.17
Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. I. Eosinophilia and immunologic responses to a schistosomal egg preparation. Am J Pathol (1973) 1.14
Intradermal immune responses to a schistosomal egg antigen during experimental murine Schistosoma mansoni infection. Proc Soc Exp Biol Med (1972) 1.14
The role of phospholipids in schistosome granulomas. J Infect Dis (1971) 0.95
A collagenaselike substance produced by eggs of Schistosoma mansoni. J Parasitol (1968) 0.94
Discussion of the paper by Kenneth S. Warren: "pathophysiology and pathogenesis of hepatosplenic schistosomiasis Mansoni". Bull N Y Acad Med (1968) 0.87
Histochemical observations of alkaline phosphatase in Schistosoma mansoni. J Infect Dis (1959) 0.86
Inhibition of granuloma formation and prolonged survival in experimental schistosomiasis. J Reticuloendothel Soc (1972) 0.82
Studies on the effects of bacteria on experimental schistosome infections in animals. Trans R Soc Trop Med Hyg (1972) 0.82
Histochemical demonstration of an acetylcholinesterase in the ova of Schistosoma mansoni. J Histochem Cytochem (1958) 0.81
C3 shunt activation in human serum chelated with EGTA. J Immunol (1972) 6.94
Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol (1993) 2.92
Relapsing pneumococcal bacteremia in immunocompromised patients. Clin Infect Dis (1992) 2.54
Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun (1975) 2.32
Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid. Infect Immun (1975) 2.04
Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin. J Immunol (1973) 1.89
Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg (1993) 1.87
Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg (1997) 1.83
Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg (1993) 1.73
Immune responses to a soluble schistosomal egg antigen preparation during chronic primary infection with Schistosoma mansoni. J Immunol (1975) 1.72
Cellular differentiation in the thymus. 3. Surface properties of rat thymus and lymph node cells separated on density gradients. J Exp Med (1970) 1.60
Activation of the classic and alternate complement pathways by endotoxin. J Immunol (1974) 1.58
Rhodococcus equi infections of humans. 12 cases and a review of the literature. Medicine (Baltimore) (1994) 1.54
The role of opsonins in recovery from experimental pneumococcal pneumonia. J Infect Dis (1980) 1.42
Immunologic aspects of host responses to schistosomiasis: resistance, immunopathology, and eosinophil involvement. Prog Allergy (1978) 1.39
Schistosomiasis vaccine:research to development. Parasitol Today (1998) 1.38
Adoptive suppression of granuloma formation. J Exp Med (1976) 1.38
Schistosomal egg antigen-induced lymphocyte blastogenesis in experimental murine Schistosoma mansoni infection. J Immunol (1971) 1.33
Schistosoma mansoni: simplified method for the production of schistosomules. Exp Parasitol (1974) 1.30
Immune responses during human schistosomiasis mansoni. V. Suppression of schistosome antigen-specific lymphocyte blastogenesis by adherent/phagocytic cells. J Immunol (1979) 1.30
Immune responses during human schistosomiasis mansoni. III. Regulatory effect of patient sera on human lymphocyte blastogenic responses to schistosome antigen preparations. Am J Trop Med Hyg (1977) 1.29
Immune responses during human schistosomiasis mansoni. I. In vitro lymphocyte blastogenic responses to heterogeneous antigenic preparations from schistosome eggs, worms and cercariae. Int Arch Allergy Appl Immunol (1977) 1.28
Functional and morphologic changes during experimental Rocky Mountain spotted fever in guinea pigs. Lab Invest (1976) 1.28
Evidence for quantitative variability of bacterial opsonic requirements. Infect Immun (1978) 1.28
Modulation of Schistosoma mansoni egg-induced granuloma formation: I-J restriction of T cell-mediated suppression in a chronic parasitic infection. Proc Natl Acad Sci U S A (1981) 1.27
Prevalence of trachoma in school children and ophthalmological outpatients in rural Egypt. Am J Trop Med Hyg (1987) 1.27
The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. AIDS (2000) 1.26
Genetic analysis of Streptococcus pneumoniae serotypes with the use of DNA fingerprinting. J Infect Dis (1989) 1.26
Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function. Infect Immun (1977) 1.25
Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. Pneumococcus Study Group. J Infect Dis (1993) 1.24
Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection. J Infect Dis (2001) 1.24
In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni. Reduction of irradiated cercariae-induced resistance. J Immunol (1988) 1.23
Adoptive suppression of granuloma formation by T lymphocytes and by lymphoid cells sensitive to cyclophosphamide. Cell Immunol (1979) 1.23
Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Am J Trop Med Hyg (1998) 1.20
Eosinophils and immune mechanisms: production of the lymphokine eosinophil stimulation promoter (ESP) in vitro by isolated intact granulomas. J Reticuloendothel Soc (1975) 1.19
Schistosoma mansoni: eosinophilia and the development of lymphocyte blastogenesis in response to soluble egg antigen in inbred mice. Exp Parasitol (1972) 1.17
Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol (1994) 1.16
Immune responses during human schistosomiasis mansoni. IV. Induction of suppressor cell activity by schistosome antigen preparations and concanavalin A. J Immunol (1978) 1.15
Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. I. Eosinophilia and immunologic responses to a schistosomal egg preparation. Am J Pathol (1973) 1.14
Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol (1996) 1.14
Intradermal immune responses to a schistosomal egg antigen during experimental murine Schistosoma mansoni infection. Proc Soc Exp Biol Med (1972) 1.14
Mixed lymphocyte blastogenesis in response to multiple histocompatibility antigens. J Immunol (1969) 1.12
Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment. Am J Trop Med Hyg (2000) 1.11
T lymphocytes that contribute to the immunoregulation of granuloma formation in chronic murine schistosomiasis. J Immunol (1981) 1.08
Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986. Medicine (Baltimore) (1990) 1.07
Cytokine regulation of human immune response to Schistosoma mansoni: analysis of the role of IL-4, IL-5 and IL-10 on peripheral blood mononuclear cell responses. Scand J Immunol (1997) 1.06
Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans R Soc Trop Med Hyg (1995) 1.04
Cytotoxic effect of normal rabbit serum on rat lymphoid cells. Transplantation (1970) 1.04
Trypan blue inhibits complement-mediated phagocytosis by human polymorphonuclear leukocytes. J Immunol (1978) 1.04
Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease. Am J Trop Med Hyg (1993) 1.03
Immune responses during human Schistosomiasis mansoni. VIII. Differential in vitro cellular responsiveness to adult worm and schistosomular tegumental preparations. Am J Trop Med Hyg (1983) 1.02
Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease. Am J Trop Med Hyg (1986) 1.02
Eosinophil-mediated destruction of Schistosoma mansoni eggs III. lymphokine involvement in the induction of eosinophil functional abilities. Cell Immunol (1978) 1.01
Immune responses during human schistosomiasis mansoni. VI. In vitro nonspecific suppression of phytohemagglutinin responsiveness induced by exposure to certain schistosomal preparations. J Immunol (1979) 1.00
Partial purification and characterization of Schistosoma mansoni soluble egg antigen with Con A-Sepharose chromatography. J Immunol (1979) 1.00
Immunoaffinity purification of Schistosoma mansoni soluble egg antigens. J Immunol (1979) 0.98
Human antibody responses against schistosomal antigens. I. Antibodies from patients with Ancylostoma, Ascaris lumbricoides or Schistosoma mansoni infections react with schistosome antigens. Am J Trop Med Hyg (1988) 0.98
Immune responses during human schistosomiasis mansoni. XVIII. Immunologic status of pregnant women and their neonates. Scand J Immunol (1992) 0.98
Comparison of antibody isotype responses to Schistosoma mansoni antigens by infected and putative resistant individuals living in an endemic area. Parasite Immunol (1995) 0.98
Idiotypic sensitization in utero of children born to mothers with schistosomiasis or Chagas' disease. J Clin Invest (1989) 0.97
Self and nonself stimulatory molecules induce preferential expansion of CD5+ B cells or activated T cells of chagasic patients, respectively. Scand J Immunol (2000) 0.97
Schistosoma mansoni: relationship of tumor necrosis factor-alpha to morbidity and collagen deposition in chronic experimental infection. Exp Parasitol (1996) 0.96
Eosinophil-mediated destruction of Schistosoma mansoni eggs. J Reticuloendothel Soc (1976) 0.96
Spleen cells from Schistosoma mansoni-infected mice produce diffusible stimulator of eosinophilopoiesis in vivo. Nature (1976) 0.95
Cellular differentiation in the thymus. II. Thymus-specific antigens in rat thymus and peripheral lymphoid cells. J Immunol (1970) 0.94
Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment. Trans R Soc Trop Med Hyg (1986) 0.94
The gibbon (Hylobates lar); a new primate host for Herpesvirus hominia. I. A natural epizootic in a laboratory colony. J Infect Dis (1969) 0.94
Introducing case management to a general medicine ward team of a teaching hospital. Acad Med (1997) 0.94
Eosinophils and immune mechanisms. IV. Culture conditions, antigen requirements, production kinetics and immunologic specificity of the lymphokine eosinophil stimulation promoter. Cell Immunol (1976) 0.93
Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections. Am J Pathol (1993) 0.92
Schistosoma japonicum soluble egg antigens: separation by can A chromatography and immunoaffinity purification. Mol Immunol (1981) 0.92
Eosinophils and immune mechanisms. II. Partial characterization of the lymphokine eosinophil stimulation promoter. J Immunol (1974) 0.92
Schistosoma mansoni: susceptibility differences between male and female mice can be mediated by testosterone during early infection. Exp Parasitol (1997) 0.92
Neonatal exposure to idiotype induces Schistosoma mansoni egg antigen-specific cellular and humoral immune responses. J Immunol (1999) 0.92
Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy. Parasite Immunol (1996) 0.91
Chronic pulmonary histoplasmosis. Medicine (Baltimore) (1976) 0.91
Activation of the alternative complement pathway by Sporothrix schenckii. Infect Immun (1986) 0.91
Eosinophils and immune mechanisms. III. Production of the lymphokine eosinophil stimulation promoter by mouse T lymphocytes. J Immunol (1976) 0.90
Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival patterns in experimental Schistosoma mansoni infections. J Exp Med (1999) 0.90
Immune responses during human schistosomiasis mansoni. XVI. Idiotypic differences in antibody preparations from patients with different clinical forms of infection. J Immunol (1989) 0.90
T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of Vbeta5 expressing T cells. Scand J Immunol (2000) 0.89
Immunoregulatory idiotypes stimulate T helper 1 cytokine responses in experimental Schistosoma mansoni infections. J Immunol (1997) 0.89
Modulation of Schistosoma mansoni egg-induced granuloma formation. III. Evidence for an anti-idiotypic, I-J-positive, I-J-restricted, soluble T suppressor factor. J Immunol (1984) 0.89
Immune responses during human schistosomiasis mansoni. IX. T-lymphocyte subset analysis by monoclonal antibodies in hepatosplenic disease. Scand J Immunol (1983) 0.88
Schistosoma mansoni: mortality, pathophysiology, and susceptibility differences in male and female mice. Exp Parasitol (1992) 0.88
An electrophoretic analysis of Schistosoma mansoni soluble egg antigen preparation. J Parasitol (1978) 0.88
Intraductal carcinoma of the prostate gland. J Urol (1973) 0.87
Mouse model for Chagas disease: immunohistochemical distribution of different stages of Trypanosoma cruzi in tissues throughout infection. Am J Trop Med Hyg (2001) 0.87
Complement-dependent platelet injury by staphylococcal protein A. J Exp Med (1972) 0.87
Immunopathology of dermal reactions induced by Schistosoma mansoni cercariae and cercarial extract. Am J Trop Med Hyg (1972) 0.87
Arachidonic acid metabolism of the murine eosinophil. II. Involvement of the lipoxygenase pathway in the response to the lymphokine eosinophil stimulation promoter. J Immunol (1982) 0.87
IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni. Parasite Immunol (1997) 0.87
Serologic responses to Schistosoma japonicum: evaluation of total and parasite-specific immunoglobulins during the course of murine infection. J Parasitol (1982) 0.87